IGC Pharma, Inc.IGCNYSE
Loading
Operating cash flow minus capital expenditures
Latest
$-5.28M
↑ 12% vs avg
Percentile
P36
Within normal range
Streak
5 yr
Consecutive growthContracting
Average
$-5.98M
Historical baseline
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $-5.28M | +7.6% |
| 2024 | $-5.71M | +25.5% |
| 2023 | $-7.67M | +6.9% |
| 2022 | $-8.23M | +33.6% |
| 2021 | $-12.39M | +5.7% |
| 2020 | $-13.14M | -287.7% |
| 2019 | $-3.39M | -59.0% |
| 2018 | $-2.13M | -38.7% |
| 2017 | $-1.54M | -449.1% |
| 2016 | $-279887.00 | - |